Evidence map›Paper›PMID 33468084›Full record

ArticleBMC cancer2021

Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area.

Che-Wei Chang, Chien-Hui Ou, Chih-Chin Yu, Chi-Wen Lo, Chung-You Tsai, Pai-Yu Cheng, Yung-Tai Chen, Hsu-Che Huang, Chia-Chang Wu, Ching-Chia Li and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Arsenic and cancer: Evidence and mechanisms.Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Che-Wei ChangDepartment of Urology, Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung, Taiwan.
Chien-Hui OuDepartment of Urology, National Cheng-Kung University Hospital, Tainan, Taiwan.
Chih-Chin YuDepartment of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Chi-Wen LoDepartment of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Chung-You TsaiDepartment of Urology, Far-Eastern Memorial Hospital, New Taipei City, Taiwan.
Pai-Yu ChengDepartment of Urology, Far-Eastern Memorial Hospital, New Taipei City, Taiwan.
Yung-Tai ChenDepartment of Urology, Taiwan Adventist Hospital, Taipei, Taiwan.
Hsu-Che HuangDepartment of Urology, Cardinal Tien Hospital, New Taipei City, Taiwan.
Chia-Chang WuDepartment of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Ching-Chia LiDepartment of Urology, Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung, Taiwan.
Hsiang-Ying LeeDepartment of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan. ashum1009@hotmail.com.ORCID http://orcid.org/0000-0003-2405-4874
Far Eastern Memorial Hospital · TWKaohsiung Medical University Chung-Ho Memorial Hospital · TWTaipei Tzu Chi Hospital · TWCardinal Tien Hospital · TWKaohsiung Municipal Ta-Tung Hospital · TWNational Cheng Kung University Hospital · TWTaipei Medical University-Shuang Ho Hospital · TWTaiwan Adventist Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA high incidence of upper urinary tract urothelial carcinoma has been reported in the southwestern area of Taiwan, where arsenic water contamination was considered the main cause. However, there is no definite proof to show a correlation between arsenic water contamination and upper urinary tract urothelial carcinoma. To investigate the clinical and epidemiological features of patients with upper urinary tract urothelial carcinoma between arsenic water endemic and non-endemic areas, we analyzed patients in terms of characteristics, stratified overall survival, disease-free survival, and cancer-specific survival.

methodsThe records of a total of 1194 patients diagnosed with upper urinary tract urothelial carcinoma were retrospectively reviewed. Clinical data and current medical status were collected from the medical records. Statistical analyses were performed to determine the clinical variables and stratified survival curves between endemic and non-endemic groups.

resultsFemale predominance was revealed in both endemic and non-endemic groups (male:female ratio = 1:1.2-1.4). No statistical differences were found in histological types, staging, and tumor size between the two groups. Nonetheless, patients with characteristics of aging and having end-stage renal disease were outnumbered in the non-endemic group, while a higher prevalence of previous bladder tumors and more ureteral tumors were found in the endemic group. Adjusted stratified cumulative survival curves suggested a poorer prognosis in endemic patients, especially in disease-free survival of early stage disease.

conclusionsA higher mortality rate with more previous bladder cancer history and ureteral tumors was seen in patients with upper urinary tract urothelial carcinoma residing in the arsenic water contamination area. This may be attributed to the long-term carcinogenic effect of arsenic underground water.

Indexed as

AgedArsenicalsCarcinoma, Transitional CellDisease-Free SurvivalEndemic DiseasesFemaleGeographyHumansIncidenceKidney NeoplasmsMaleMiddle AgedPeripheral Vascular DiseasesPrognosisRetrospective StudiesRisk FactorsArsenicalsArsenicBlack foot diseaseClinicopathological featuresPrognosisUpper urinary tract urothelial carcinoma

Identifiers

PMID33468084
PMCPMC7816491
OpenAlexW3121459029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.